Clinical trials: GAD Ab Positive Clinically Type 2 Diabetic Patients
GAD Ab Positive Clinically Type 2 Diabetic Patients
Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes
We tested the hypothesis that insulin therapy rather than sulfonylurea (SU) treatment has a preferable outcome to reverse or preserve beta cell function in the patients with diabetes that is called slowly progressive…
- Trial name
- NCT00232375
- Testing
- Insulin
- Where
- Japan
- Volunteers
- 42 people
- Sponsor
- Tokyo Study Group